# Track 2 harness review, v48

22 October 2026. This is the current presentation and research consistency review
for the v48 presentation layer. It inherits the v47 review boundaries and adds the
v48 revision/route and no-slop wording checks. It does not add biological
evidence, literature, a GPU campaign, a recorded video, an upload, or a drug
decision.

## Current routes

- Report: `notes/track2-report-v53.md`
- Slides: `notes/track2-slides-v53.html`
- Combined public review: `scripts/track2_public_review_v53.py`
- Release: `scripts/track2_release_v53.py`
- Deck renderer: `scripts/render_track2_slides_v53.mjs`
- Document exporter: `scripts/track2_export_documents_v53.py`
- Report renderer: `scripts/render_track2_report_v53.mjs`
- Recording-materials bundle: `scripts/track2_bundle_v53.py`
- Latest requirements refresh: `notes/track2-requirements-review-v53.md`
- Submission checklist: `notes/track2-submission-prep-v3.md`
- Exact submission materials: `notes/track2-submission-materials-v5.json`
- Current state: `notes/track2-current.json`
- Design note: `notes/track2-v48-design.md`

Frozen v47 inputs, render audits, exports, snapshot, and bundle remain available
under their original names. Historical v1-v40 snapshots and all earlier research
addenda remain unchanged and preserved.

## Checks performed

- Full inherited v47 public review.
- V48 route and revision checks.
- No-slop wording scan, with the required BEACON sponsor acknowledgement exempt
  because it is the sponsor's name.
- Nine-slide geometry: no outside text, no overlaps, minimum 24 px font.
- PDF/font and accessibility contrast checks.
- Methods workbook round-trip and template preservation.
- v48 release snapshot integrity and historical preservation.
- v48 recording-materials bundle integrity.

## Verification architecture

The current release snapshot is preserved at
`results/feat009/jvv7_track2_research_v48-verified154`. Later current-route updates
do not rewrite that snapshot. The harness scripts check live files, while the
snapshot binds the presentation/research inputs. The harness check/audit/test
scripts are therefore not snapshot-bound inputs; binding them would make every
current-route update invalidate the immediately preceding snapshot. The current
harness audit and tests bind those scripts instead.

## Explicit limits

This is a presentation-layer review only. It does not establish biological
validation, recording runtime, hosting access, provider settings, licensing
scope, quota, upload readiness, phase, clinical exposure, efficacy, or prize
eligibility. Everolimus remains a mechanistic probe on HOLD; HCQ remains reserve.
No rescue-priority drug exists.
